<SEC-DOCUMENT>0000947871-20-000405.txt : 20200424
<SEC-HEADER>0000947871-20-000405.hdr.sgml : 20200424
<ACCEPTANCE-DATETIME>20200424170024
ACCESSION NUMBER:		0000947871-20-000405
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20200424
DATE AS OF CHANGE:		20200424
EFFECTIVENESS DATE:		20200424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		20815851

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>ss172308_defa14a.htm
<DESCRIPTION>DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">
<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt/15pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SCHEDULE 14A</B></P>

<P STYLE="font: 10pt/15pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/15pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PROXY STATEMENT PURSUANT TO SECTION
14(a) OF THE</B><BR>
<B>SECURITIES EXCHANGE ACT OF 1934&nbsp;&nbsp; (Amendment No. &nbsp; &nbsp; )</B></P>

<P STYLE="font: 10pt/15pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 2%; padding-right: 8pt; line-height: 14pt"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&nbsp;&#9745;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 59%; line-height: 14pt">Filed by the Registrant</TD>
    <TD STYLE="white-space: nowrap; width: 3%; padding-right: 8pt; line-height: 14pt"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 34%; line-height: 14pt">Filed by a Party other than the Registrant</TD>
    <TD STYLE="white-space: nowrap; width: 2%; line-height: 14pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="white-space: nowrap; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt; line-height: 14pt">CHECK THE APPROPRIATE BOX:</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="white-space: nowrap; width: 3%; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt; line-height: 14pt"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 2%; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt; line-height: 14pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 95%; border-bottom: black 1pt solid; line-height: 14pt">Preliminary Proxy Statement</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt; line-height: 14pt"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt; line-height: 14pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; line-height: 14pt">Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt; line-height: 14pt"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt; line-height: 14pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; line-height: 14pt">Definitive Proxy Statement</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt; line-height: 14pt"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9745;</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt; line-height: 14pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; line-height: 14pt">Definitive Additional Materials</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt; line-height: 14pt"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt; line-height: 14pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; line-height: 14pt">Soliciting Material Under Rule 14a-12</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 24px; width: 133px"></P>

<P STYLE="font: 14pt/120% Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CVS HEALTH CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0 6pt; text-align: center">(Name of Registrant as Specified In
Its Charter)<BR>
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt; line-height: 14pt">PAYMENT OF FILING FEE (CHECK THE APPROPRIATE BOX):</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt; line-height: 14pt"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9745;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt; line-height: 14pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; line-height: 14pt">No fee required.</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-right: 4pt; padding-left: 4pt; line-height: 14pt"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="padding-right: 4pt; padding-left: 4pt; line-height: 14pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="line-height: 14pt">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="width: 1%; padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="width: 97%"><FONT STYLE="font-size: 7.5pt">1) Title of each class of securities to which transaction applies:</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD><FONT STYLE="font-size: 7.5pt">2) Aggregate number of securities to which transaction applies:</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-right: 4pt; padding-left: 4pt; line-height: 14pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 4pt; line-height: 14pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 4pt; line-height: 14pt">&nbsp;</TD>
    <TD><FONT STYLE="font-size: 7.5pt">3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD><FONT STYLE="font-size: 7.5pt">4) Proposed maximum aggregate value of transaction:</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7.5pt">5) Total fee paid:</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt; line-height: 14pt"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt; line-height: 14pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; line-height: 14pt">Fee paid previously with preliminary materials:</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-right: 4pt; padding-left: 4pt; line-height: 14pt"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></TD>
    <TD STYLE="padding-right: 4pt; padding-left: 4pt; line-height: 14pt">&nbsp;</TD>
    <TD COLSPAN="2">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.</TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD><FONT STYLE="font-size: 7.5pt">1) Amount previously paid:</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD><FONT STYLE="font-size: 7.5pt">2) Form, Schedule or Registration Statement No.:</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD><FONT STYLE="font-size: 7.5pt">3) Filing Party:</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7.5pt">4) Date Filed:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&nbsp;</P>
<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt;"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>CVS HEALTH CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>SUPPLEMENT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>NOTICE OF 2020 ANNUAL
MEETING OF STOCKHOLDERS AND</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>PROXY STATEMENT</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>Annual Meeting of
Stockholders to be held on May 14, 2020</B></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 10pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In 2017, the stockholders of CVS Health Corporation (&ldquo;CVS
Health&rdquo;) approved the 2017 Incentive Compensation Plan, under which shares of CVS Health common stock were authorized to be
issued as part of incentive compensation to eligible employees and non-employee members of the Board of Directors. The 2017 Incentive
Compensation Plan limits the number of options, shares of restricted stock, restricted stock units, shares of deferred stock and
shares of CVS Health stock issued as a bonus or in lieu of other obligations, and other stock-based awards granted to any one participant
to not more than one million shares for each type of such award during any fiscal year.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">In August 2019, the Management Planning and Development Committee
of CVS Health&rsquo;s Board of Directors approved accelerating the grant date of the 2020 annual performance stock unit award of
Larry Merlo, CVS Health&rsquo;s President and Chief Executive Officer. That grant, which would have otherwise been made in 2020,
was made on August 30, 2019 and was in lieu of a 2020 performance stock unit award; Mr. Merlo&rsquo;s 2019 performance stock unit
award was made on June 5, 2019. Although the hypothetical aggregate number of shares of CVS Health common stock to be issued under
both performance stock unit awards made in 2019 could be greater than one million shares of CVS Health stock in the event that
the maximum performance levels were achieved, the grants to Mr. Merlo are capped under the terms of the 2017 Incentive Compensation
Plan and the related award agreements to a total of no more than one million shares of CVS Health common stock.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Important Information</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">This supplement should be read in conjunction with CVS Health&rsquo;s
definitive proxy statement on Schedule 14A (the &ldquo;Proxy Statement&rdquo;), which was filed with the Securities and Exchange
Commission on April 3, 2020 <FONT STYLE="background-color: white">in connection with CVS Health&rsquo;s Annual Meeting of Stockholders
to be held on May 14, 2020</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">If you have already voted, you do not need to vote again unless
you would like to change or revoke your prior vote on any proposal.&nbsp; If you would like to change or revoke your prior vote
on any proposal, please refer to page 94 of the Proxy Statement for instructions on how to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><IMG SRC="image_001.jpg" ALT=""></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  8 (4# 2(  A$! Q$!_\0
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MIMN;II%'WCG![\=:Z3YUJSL=K>ZSI^BP1'5]2M;9F &Z:18]Y[D FKD=Q%-
ML\4J/"PW"16!4CUS7F>F?VC?>*O$ETOAZSUB>*]-N)+JZ5##$H&U%0J<#J<]
M_P *H7ME?Z=I-[8WD<.FZ3?:Q;1RVUO="46T3_ZT9 &P$@'MUH$>FP>)-&N?
M/\C5;&3[/_K=LZG9]>>*Q!KUU%X]2UDU&WET:XT][Q"$4"/:5&=^>1R361\3
MO#NB6G@AY8K.VM);=XUMS%&$)RP&SCJ"/7TJ\]K ?B9IMMY,?D'1)4,6P;-O
MF+QCICVH BU#QM)JG@74-8T*ZBM;JQ,C-$^V8E58KR.P;&0:Z:P\0:;=3167
M]HVCZ@8U9[=95W@X!/RYSWKSVRM;>'X,:_+%!$DC-=*75 "0)6P"?05I^+]!
MTW2?A@;FPLXH+JRC@F@G10)$?<OS;NI/)_.@#T2BFH<HI/4@&B@!<9K+M_#>
MF6NM2ZK#;*MW*,,W8>I [$]S110T4I..SW-3%<UJOP_T35;M[F2*2&5SES"^
MT,?ITHHI-)[CIU9TW>#L:&B>&M-\/QL-/@VN_P!^1CN9OQJI<^!]%N]5;49K
M=C<-()&(<X+#OC\***.5;%>WJ<SES.[+^LZ!I^O6XAU" 2!3E&!PRGV(K&L?
MAOH-E<K,8I9V0[@LKY7/T[_C112Y4]6.->K"/+&32+UWX/TV]UZ/6)6NQ>1$
M;"EPRJH&. H.,' R.].U[PGIWB.:WEU W.ZW.Z,13L@5NS8'?GK115&)'?\
M@W3KV\%Y'->V5YY:QO<6=PT3RJ.@<C[WU/-3V_A31[;19]*6S5[2XR9UD)9I
M6/5F8\D^_;M110!EO\-]$N(#!>O?WD2C;"ES=NX@'^QZ=.O6M)_"FGR76FW1
M:Z%SIRA(I1.VYDR#M<_Q#@=:** *DG@'1Y+:]M<WB6MY)YDL"7+A,DDG SP"
M3R/I5B]\(:;J&@1:-=-=R64?8W#;FYSAFSDCV/H*** -6QLTL+.*VB>5TB7:
-&E<NQ^I/)HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
